Shandong Xinhua Pharmaceutical Company Limited (FRA:XIN)

FRA:XIN Revenue

Shandong Xinhua Pharmaceutical Company had revenue of 2.12B CNY in the quarter ending September 30, 2025, with 6.10% growth. This brings the company's revenue in the last twelve months to 8.49B, up 1.89% year-over-year. In the year 2024, Shandong Xinhua Pharmaceutical Company had annual revenue of 8.47B with 4.51% growth.

• Revenue (ttm): 8.49B CNY
• Revenue Growth: +1.89%
• P/S Ratio: 1.20
• Revenue / Employee: 1.16M CNY
• Employees: 7,296
• Market Cap: 1.22B EUR

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.47B	365.47M	4.51%
Dec 31, 2023	8.10B	597.86M	7.97%
Jan 1, 2023	7.50B	942.91M	14.37%
Dec 31, 2021	6.56B	554.49M	9.23%
Dec 31, 2020	6.01B	399.57M	7.13%